by Alex Watkins ONeill | Apr 8, 2025 | Content
Six decades ago, researchers identified two transformative medical strategies that provided immense hope for managing two major public health problems. One was introducing the concept that depression originated from altered levels of brain chemicals, the other was...
by Alex Watkins ONeill | Apr 1, 2025 | Content
In 2022 the FDA warned, based on adverse event reports, that transmucosal (sublingual and buccal) buprenorphine may cause dental problems, such as tooth decay, cavities, oral infections, or loss of teeth. This study used insurance claims data from 2002 to 2019 for...
by Alex Watkins ONeill | Mar 18, 2025 | Content
A recent study analyzing data from the National Survey on Drug Use and Health (NSDUH) found that past-year recreational ketamine use among adults has increased dramatically since 2015, including significant shifts in associations with depression and sociodemographic...
by Alex Watkins ONeill | Mar 11, 2025 | Content
This Advisory describes the scientific evidence for the causal link between alcohol consumption and increased risk for at least seven different types of cancer, including breast (in women), colorectum, esophagus, voice box, liver, mouth, and throat. The Advisory also...
by Alex Watkins ONeill | Mar 4, 2025 | Content
The Biden administration finalized a long-awaited rule in January, laying out how some health care providers can prescribe gold-standard opioid use disorder treatments through telehealth. The final rule from the Drug Enforcement Administration and the Substance Abuse...
by Alex Watkins ONeill | Feb 25, 2025 | Content
This review article is a comprehensive discussion about most aspects of alcohol use disorder (AUD), including the neurobiology and definition of AUD, diagnostic criteria, and screening instruments. The authors describe biological markers useful for detecting and...
Recent Comments